Responses

Download PDFPDF

Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    HCV genotype 2 as risk factor for reactivation of chronic HCV infection
    • Evangelista Sagnelli, full professor of Infectious Diseases
    • Other Contributors:
      • Nicola Coppola, Luisa Maria Vatiero, Evangelista Sagnelli

    Dear Editor,

    Little information is available in the literature on the acute exacerbation of chronic hepatitis C (r-CHC) [1-6]. In Taiwan, Dr. Sheen estimated an annual incidence rate of 11.9% [3]. In this study 40.2% of 78 patients experienced at least one episode of reactivation during a mean observation period of 6 years and a total of 151 episodes of reactivation were observed, 45% of them symptomatic. The pap...

    Show More
    Conflict of Interest:
    None declared.